A new nomogram was developed to estimate the prognosis of colon cancer patients using the CEA-TD score combined with four additional clinical variables: T stage, N stage, histological grade, and tumor location (Figure 5A). This evidence concerns the gene CEACAM5 and malignant colon neoplasm.